2020
DOI: 10.1016/j.nicl.2020.102329
|View full text |Cite
|
Sign up to set email alerts
|

Diaschisis revisited: quantitative evaluation of thalamic hypoperfusion in anterior circulation stroke

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 30 publications
0
5
0
Order By: Relevance
“…Recently, the 2 largest studies from Reidler report no independent impact of thalamic hypoperfusion on clinical outcome in hyperacute 2 and acute stroke. 3 However, Kuchcinski et al 30 showed a delayed deposition of iron in the thalamus as a marker of neurodegeneration is independently associated with clinical outcomes 1 year after the acute event.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Recently, the 2 largest studies from Reidler report no independent impact of thalamic hypoperfusion on clinical outcome in hyperacute 2 and acute stroke. 3 However, Kuchcinski et al 30 showed a delayed deposition of iron in the thalamus as a marker of neurodegeneration is independently associated with clinical outcomes 1 year after the acute event.…”
Section: Discussionmentioning
confidence: 99%
“…to 85%. [2][3][4][5] It has been well established in ischemia experimental models that acute diaschisis may be attributed to excitotoxicity and deafferentiation, 6 whereas chronic diaschisis is probably caused by transneuronal degeneration and may result in long-term structural changes, such as ipsilateral thalamic atrophy. 7 Although diaschisis initially describes a reversible functional phenomenon, accumulating evidence has shown that morphological changes also occur in remote but connected brain regions.…”
Section: Clinical and Population Sciencesmentioning
confidence: 99%
See 2 more Smart Citations
“…Moreover, an insufficient perfusion volume of >3.5 ml, as observed on CTP, can be used to identify patient subgroups with poor clinical prognosis and differentiate them from patients with delayed recovery. [ 37 ]…”
Section: Clinical Assessment Of the No-reflow Phenomenonmentioning
confidence: 99%